(Q48315117)

10 February 2018

title

Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's disease (English)

1 reference

https://api.crossref.org/works/10.1016/S1388-2457(03)00040-3

31 December 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1388-2457(03)00040-3

31 December 2023

5

John Nutt

1 reference

10 February 2018

Jau-Shin Lou

1

1 reference

10 February 2018

Theodore Benice

2

1 reference

10 February 2018

Greg Kearns

3

1 reference

10 February 2018

Gary Sexton

4

1 reference

10 February 2018

John Nutt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738440

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738440

31 December 2023

publication date

1 May 2003

1 reference

10 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S1388245703000403?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1388-2457(03)00040-3

https://api.elsevier.com/content/article/PII:S1388245703000403?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1388-2457(03)00040-3

31 December 2023

published in

Clinical Neurophysiology

1 reference

10 February 2018

volume

114

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

930-937

1 reference

10 February 2018

Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Postexercise depression of motor evoked potentials: a measure of central nervous system fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Central fatigue as revealed by postexercise decrement of motor evoked potentials

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Impairment of motor cortex activation and deactivation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Age-dependent decline in motor evoked potential (MEP) amplitude: with a comment on changes in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Spinal motor neuron excitability during the silent period after cortical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Neural control in human muscle fatigue: changes in muscle afferents, motoneurones and motor cortical drive [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Exacerbated physical fatigue and mental fatigue in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Changes in excitability of motor cortical circuitry in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Characterization of postexercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Changes in motor cortical excitability during human muscle fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1388-2457%2803%2900040-3

1 reference

7 January 2021

Identifiers

1 reference

10 February 2018

1 reference

10 February 2018